logo
Select company
Select metric
1.61Cash Ratio
VS
Market
77
Sector
56
Industry
42
History
25
$ 2Close
$ 0.71 - $ 2.05 52-Week Range
Ticker Information

Ticker

IRD

Company Name

OPUS GENETICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

OPUS GENETICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IRD - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 32.43M1.61$ 20.19M
3/31/2025$ 41.79M1.72$ 24.25M
12/31/2024$ 30.32M2.68$ 11.29M
9/30/2024$ 36.63M6.02$ 6.09M
6/30/2024$ 41.41M9.86$ 4.2M
3/31/2024$ 47.16M8.15$ 5.79M
12/31/2023$ 50.5M12.49$ 4.04M
9/30/2023$ 42.35M10.83$ 3.91M
6/30/2023$ 39.98M6.94$ 5.76M
3/31/2023$ 38.99M9.39$ 4.15M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • OPUS GENETICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 2.69.
  • Over the past 5 years, OPUS GENETICS INC's average Cash Ratio has been 6.88.
  • The median Cash Ratio for OPUS GENETICS INC during this period was 6.19
  • OPUS GENETICS INC reached its highest Cash Ratio over the past 5 years at 15.49.
  • The lowest Cash Ratio recorded by OPUS GENETICS INC in the same timeframe 1.61

OPUS GENETICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
VRCA : VERRICA PHARMACEUTICALS INC 0.53BRNS : BARINTHUS BIOTHERAPEUTICS PLC 6.9EQ : EQUILLIUM INC 1.59HYFT : MINDWALK HOLDINGS CORP 0.3XLO : XILIO THERAPEUTICS INC 2.32CUE : CUE BIOPHARMA INC 1.54SRZN : SURROZEN INC 15.86WHWK : WHITEHAWK THERAPEUTICS INC 16.55OVID : OVID THERAPEUTICS INC 3.4SEER : SEER INC 3.26

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for OPUS GENETICS INC is calculated as follows: CashnEq [ $ 8.08M ] / LiabilitesC [ $ 3.01M ]
(=) Cash Ratio [ 2.69 ]

IRD - Cash Ratio, Last 5 years

1.61

Minimum

Jun 30, 2025

15.49

Maximum

Dec 31, 2022

6.88

Average

6.19

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63